T cell plays multiple roles in tumor biology. On one hand, T cells can become cancerous due to dysregulated proliferation and survival. On the other hand, T cell is a critical component of anti-tumor immunity that constantly surveys our body to recognize and eradicate tumor cells as """"""""foreign"""""""" pathogens. In addition, a subset of CD4 T cells, namely regulatory T cells (Treg), potently suppresses immune cell mediated tumor rejection and thus promotes tumor outgrovi^th. To maintain a healthy, tumor-free body, the development, proliferation, survival and function of T cells have to be tightly regulated. Using a conditional gene knock-out mouse model, we have found that TGF-beta activated kinase 1 (TAKl), one of the mitogen activated protein kinase kinase kinases (MAP3K), controls virtually every aspect of T cell physiology from the development to function, potentially through regulating NFkappaB and MARK signaling pathways. To extend these studies, to investigate the underlying mechanisms by which TAKl regulates T cell function, and to test whether TAKl can potentially be an intervention target in treating various tumors/cancers in human patients, we propose to address the following specific aims:
Aim 1 : Further characterize mechanistically the role of TAKl in the development, homeostasis, and differentiation of T cells,.
Aim 2 : Address the molecular mechanisms underlying TAKl mediated common gamma chain-receptor sharing cytokine signaling in T cells.
Aim 3 : Investigate the feasibility of preventing/treating various tumors by targeting TAKl gene. The long term goal for this research is to elucidate how immune system is regulated, to further understand the etiology of and find the treatment of human T cell lymphomas/leukemias, and to apply the knowledge gained beyond immune sytem to aid the development of new drugs and therapies to treat various types of cancers in humans.

Public Health Relevance

Cancer is a disease afflicting millions of people. Immune cells, such as T cells, can become cancerous and are also critical for eradicating tumors. This study would help us to understand the roles for T cell in tumorigensis and aid our effort of designing innovative drugs/therapies agains various types of cancers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Transition Award (R00)
Project #
5R00AI072956-04
Application #
7805499
Study Section
Special Emphasis Panel (NSS)
Program Officer
Bridges, Nancy D
Project Start
2008-05-15
Project End
2011-04-30
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
4
Fiscal Year
2010
Total Cost
$249,000
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Gu, Ai-Di; Wang, Yunqi; Lin, Lin et al. (2012) Requirements of transcription factor Smad-dependent and -independent TGF-? signaling to control discrete T-cell functions. Proc Natl Acad Sci U S A 109:905-10
Wang, Yunqi; Su, Maureen A; Wan, Yisong Y (2011) An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35:337-48
Zhao, Yan G; Wang, Yunqi; Hao, Weidong et al. (2011) An essential role for TAK1 in the contact hypersensitivity response. Cell Mol Immunol 8:315-24
Wan, Yisong Y (2010) Regulatory T cells: immune suppression and beyond. Cell Mol Immunol 7:204-10
Wang, Yunqi; Souabni, Abdallah; Flavell, Richard A et al. (2010) An intrinsic mechanism predisposes Foxp3-expressing regulatory T cells to Th2 conversion in vivo. J Immunol 185:5983-92
Wan, Yisong Y; Flavell, Richard A (2009) How diverse--CD4 effector T cells and their functions. J Mol Cell Biol 1:20-36
Jani, Anant; Chi, Tian; Wan, Yisong Y (2009) Chromatin remodeling complex in Treg function. Int Immunopharmacol 9:521-3
Wan, Yisong Y; Flavell, Richard A (2008) TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol 28:647-59
Laouar, Yasmina; Town, Terrence; Jeng, David et al. (2008) TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 105:10865-70